Drug Trial Radar · NCT06098079
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
Last checked: Nov 19, 2026Latest source record: Mar 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
8,600
Planned (sponsor's estimate)
Start
Jan 3, 2024
Primary completion
Jan 2029
Study completion Jul 2029
Sponsor
- Lead sponsor
- Currax PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Oct 24, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).
Conditions
- Obesity
Interventions
Naltrexone-Bupropion (NB) CombinationDrug
A total daily dosage of two NB 8 mg/90 mg tablets twice daily (32 mg/360 mg) is reached at the start of Week 4.
PlaceboDrug
A total daily dosage of two placebo tablets twice daily (in an identical, non-medicine containing tablet) is reached at the start of Week 4.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of Cardiovascular DeathTime frame: Treatment initiation through 1 year following treatment termination.
- Occurrence of Non-fatal Myocardial Infarction (MI)Time frame: Treatment initiation through 1 year following treatment termination.
- Occurrence of Non-fatal StrokeTime frame: Treatment initiation through 1 year following treatment termination.
Locations
140 sites in 1 country. Site status is shown where the registry gives one.
TrialMed Birmingham (DRS)
Birmingham, Alabama
Accel Research Sites Network
Birmingham, Alabama
Cullman Clinical Trials
Cullman, Alabama
AMR Mobile
Mobile, Alabama
Velocity Clinical Research, Mobile
Mobile, Alabama
Sun City Research
Glendale, Arizona
Cardiovascular Consultants/NextStage Clinical Research
Glendale, Arizona
Desert Clinical Research
Mesa, Arizona
Velocity Clinical Research, Phoenix
Phoenix, Arizona
Fiel Family & Sports Medicine CCT Research
Tempe, Arizona
Synexus Clinical Research US; Inc.
Tucson, Arizona
Velocity Clinical Research, Gardena
Anderson, California
Velocity Clinical Research
Chula Vista, California
Velocity Clinical Research, Huntington Park
Huntington Park, California
Velocity Clinical Research, San Diego
La Mesa, California
Chemidox Clinical Trials Inc.
Lancaster, California
Long Beach Clinical Trials
Long Beach, California
Velocity Clinical Research
Los Angeles, California
Valley Vitality Ventures
Manteca, California
National Institute of Clinical Research, Inc.
Pomona, California
Velocity Clinical Research, San Bernardino
San Bernardino, California
Velocity Clinical Research at Coastal Heart Medical Group
Santa Ana, California
Velocity Clinical Research of Santa Ana
Santa Ana, California
Velocity Clinical Research, Van Nuys
Van Nuys, California
Providere Research
West Covina, California
Velocity Clinical Research, Denver
Englewood, Colorado
ABMED Clinical Research
Cape Coral, Florida
LMG Research
Coral Gables, Florida
JY Research Institute
Cutler Bay, Florida
Delray Physician Center
Delray Beach, Florida
D&H Doral Research Center
Doral, Florida
Accel Research Sites Network - Edgewater
Edgewater, Florida
Velocity Clinical Research (New Smyrna Beach)
Edgewater, Florida
IMRC Fort Lauderdale
Fort Lauderdale, Florida
Southwest General Healthcare Center
Fort Myers, Florida
G+C Research Group
Hialeah, Florida
Qway Research
Hialeah, Florida
Conveinent Medical Research
Hialeah, Florida
Ilumina Medical Research
Kissimmee, Florida
Altus Research
Lake Worth, Florida
Showing 40 of 140 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.